Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians

Cancer Epidemiology Biomarkers and Prevention

Volumn 7, Issue 5, 1998, Pages 385-390

  Ma, Jing ^a,e   Stampfer, Meir J ^a,b   Gann, Peter H ^d   Hough, Heather L ^a   Giovannucci, Edward ^a,b   Kelsey, Karl T ^a,b   Hennekens, Charles H ^a,b   Hunter, David J ^a,b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c HARVARD CENTER FOR CANCER PREVENTION   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; VITAMIN D; VITAMIN D RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; BONE METABOLISM; CALCIUM HOMEOSTASIS; CANCER RISK; CONTROLLED STUDY; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN POLYMORPHISM; RECEPTOR GENE; RECEPTOR UPREGULATION; UNITED STATES;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DOUBLE-BLIND METHOD; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; PHYSICIANS; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RECEPTORS, CALCITRIOL; RISK FACTORS; UNITED STATES; VITAMIN D;

EID: 0031879784     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. 3 receptors and actions in human prostate cancer cell lines. Endocrinology, 132: 1952-1960, 1993.
2. Bahnson, R R., Oeler, T., Trump, D , Smith, D , and Schwartz, G G. Inhibition of human prostatic carcinoma cell lines by 1,25-dihydroxyvitamin D3 and vitamin D analogs. J. Urol., 149 (Suppl.): 417A, 1993
3. Schwartz, G. G., Oeler, T. A., Uskokovic, M. R., and Bahnson, R. R Human prostate cancer cells: inhibition of proliferation by vitamin D analogs. Anticancer Res., 14: 1077-1082, 1994.
4. Skowronski, R. J., Peehl, D. M , and Feldman, D Actions of vitamin D3 analogs on human prostate cancer cell lines comparison with 1,25-dihydroxyvitamin D3 Endocrinology, 136: 20-26, 1995.
5. Lucia, M. S., Anzano, M. A , Slayter. M. V , Anver, M R., Green. D. M , Shrader, M. W., Logsdon, D L., Driver, C. L , Brown, C. C., and Peer, C. W. Chemopreventive activity of tamoxifen. N-(4-hydroxyphenyl)retinamide, and the vitamin D analogue Ro24-5531 for androgen-promoted carcinomas of the rat seminal vesicle and prostate Cancer Res., 55 5621-5627, 1995.
6. Schwartz, G. G., and Hulka, B S. Is vitamin D deficiency a risk factor for prostate cancer. Anticancer Res., 10: 1307-1312, 1990
7. Hanchette, C L , and Schwartz, G G. Geographic patterns of prostate cancer mortality Cancer (Phila ), 70: 2861-2869, 1992.
8. Corder, E H., Guess, H. A , Hulka, B. S., Friedman, G. D., Sadler, M , Vollmer, R. T., Lobaugh, B., Drezner, M. K , Vogelman, J. H., and Orentreich, N. Vitamin D and prostate cancer a prediagnostic study with stored sera. Cancer Epidemiol Biomark. Prev , 2: 467-472, 1993
9. Braun, M M , Helzlsouer, K J , Hollis, B. W., and Comstock, G. W. Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States). Cancer Causes Control, 6: 235-239, 1995.
10. Gann, P, H . Ma, J., Hennekens, C H., Hollis, B. W., Haddad, J G., and Stampfer. M. J. Circulating vitamin D metabolites in relation to subsequent development of prostate cancer. Cancer Epidemiol. Biomark. Prev , 5: 121-126, 1996.
11. Bouillon, R., Okamura, W H., and Norman, A W Structure-function relationships in the vitamin D endocrine system. Endocr. Rev., 16. 200-257, 1995
12. 3, are mediated exclusively through the genomic signaling pathway. Endocrinology, 137 1554-1561. 1996.
13. 3. Cancer Res , 52: 515-520, 1992.
14. Skowronski, R. J., Peehl, D M., and Feldman, D Vitamin D and prostate cancer: 1.25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines. Endocrinology, 132: 1952-1960, 1993
15. Morrison, N A., Qi, J. C., Tokita, A , Kelly, P J., Crofts, L., Nguyen, T. V , Sambrook, P. N , and Eisman, J. A. Prediction of bone density from vitamin D receptor alleles. Nature (Lond.), 367 284-287, 1994
16. Ingles, S. A., Ross, R. K., Yu, M. C., Irvine, R, A , La Pera, G , Haile, R W , and Coetzee, G. A Association of prostate cancer risk with vitamin D receptor and androgen receptor J. Natl. Cancer Inst. (Bethesda), 89. 166-170, 1997
17. Ingles, S. A , Haile, R. W., Henderson, H. B , Kolonel, L. N., Nakaichi, G , Shi, C., Yu, M C., Ross, R K., and Coetzee. G. A Strength of linkage disequilibrium between two vitamin D receptor markers in five ethnic groups: implications for association studies. Cancer Epidemiol. Biomark. Prev., 6 93-98, 1997
18. Taylor, J A , Hirvonen, A , Watson, M., Pittman, G., Mohler, J. L , and Bell, D. A. Association of prostate cancer with vitamin D receptor gene polymorphism Cancer Res., 56 4108-4110, 1996
19. Steering Committee of the Physicians Health Study Research Group. Final report of the aspirin component of the ongoing Physicians' Health Study. N Engl. J Med, 321: 129-135, 1989.
20. 125-labelled tracer. Clin Chem., 39: 529-533, 1993
21. Hollis, B. Assay of circulating 1,25-dihydroxyvitamin D involving a single-cartridge extraction and purification procedure Clin. Chem., 32: 2960-2963, 1986.
22. Haddad, J. G , Abrams, J., and Walgate, J. Affinity chromatography with 25-hydroxycholecalciferol ester in the isolation of the binding protein for vitamin D and its metabolites from human serum. Metab. Bone Dis. Relat. Res , 3: 43-46, 1981.
23. Terwilliger, J D., and Ott, J. Handbook of Human Genetic Linkage, pp 188-198. Baltimore: The Johns Hopkins University Press, 1994.
24. SAS Institute Inc. SAS/STATR User's Guide Version 6, Vol. 2, Ed. 4, p. 846. Cary, NC: SAS Institute Inc., 1989
25. van den Berg, H., Schrijver, J , and Boshuis, P. G Vitamin D (25-OHD) in serum by competitive protein-binding assay In: F. Fidanza (ed.), Nutritional Status Assessment. A Manual for Population Studies, pp. 203-209 London: Chapman & Hall, 1991
26. van den Berg, H. Fair Concerted Action No. 10 Status Papers. Vitamin D. Int. J. Vitam Nutr. Res., 63. 257-259, 1993.
27. Howard, G , Nguyen, T , Morrison, N., Watanabe, T , Sambrook, P , Eisman, J., and Kelly, P. J. Genetic influences on bone density: physiological correlates of vitamin D receptor gene alleles in premenopausal women. J Clin. Endocrinol. Metab., 80: 2800-2805, 1995.
28. Dawson-Hughes, B., Harris, S. S., and Finneran, S. Calcium absorption on high and low calcium intakes in relation to vitamin D receptor genotype J Clin Endocrinol. Metab., 80: 3657-3661, 1995.
29. Hayes, J G., Nguyen, T. V., and Need, A. G. Vitamin D receptor genotypes and fractional gut calcium absorption. J. Bone Miner. Res., 10 (Suppl. 1): P237, 1995.
30. Wishart, J. M., Horowitz, M., Need, H. A., Scopacasa, F, Morris, H. A , Clifton, P M., and Nordin, B. E. Relations between calcium intake, calcitriol, polymorphisms of the vitamin D receptor gene, and calcium absorption in premenopausal women. Am J. Clin. Nutr., 65: 798-802, 1997.
31. Cooper, G. S., and Umbach, D, M. Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis J Bone Miner. Res , 11: 1841-1849, 1996.
32. Need, A. G., Horowitz, M., Stiliano, A., Scopacasa, F., Morris, H. A., and Chatterton, B. E. Vitamin D receptor genotypes are related to bone size and bone density in men. Eur. J. Clin. Invest., 26: 793-796, 1996.
33. Sainz, J , Van Tornout, J. M., Loro, M. L., Sayre, J., Roe, T. F., and Gilsanz, V. Vitamin D-receptor gene polymorphisms and bone density in prepubertal American girls of Mexican descent. N. Engl. J. Med., 337: 77-82, 1997
34. Henry, H. L., and Norman, A. W. Vitamin D: metabolism and biological actions. Annu. Rev. Nutr., 4. 493-520, 1984.
35. Fraser, D. R. Regulation of the metabolism of vitamin D Physiol. Rev , 60: 551-613, 1980.
36. Reichel, H., Koeffler, H. P., and Norman, A. W. The role of the vitamin D endocrine system in health and disease. N. Engl. J. Med., 320. 980-991, 1989.
37. Bell, N. H., Shaw, S., and Turner, R. T. Evidence that 1,25-dihydroxyvitamin D3 inhibits the hepatic production of 25-hydroxyvitamin D in man. J. Clin. Invest., 74: 1540-1544, 1984.
38. Clements, M. R., Johnson, L., and Fraser, D. R. A new mechanism for induced vitamin D deficiency in calcium deprivation. Nature (Lond.), 325: 62-65, 1987.
39. Webb, A. R., Pilbeam, C., Hanafin, N., and Holick, M. F An evaluation of the relative contributions of exposure to sunlight and of diet to the circulating concentrations of 25-hydroxyvitamin D in an elderly nursing home population in Boston. Am. J. Clin Nutr., 51: 1075-1081, 1990.
40. 3. J. Clin. Invest, 76: 1536-1538, 1985.
41. 3. Annu. Rev Nutr., 8: 375-399, 1988.
42. Salamone, L M., Dallal, G. E., Zantos, D., Makrauer, F., and Dawson-Hughes, B. Contributions of vitamin D intake and seasonal sunlight exposure to plasma 25-hydroxyvitamin D concentration in elderly women. Am. J Clin. Nutr , 58: 80-86, 1994.
43. van der Wielen, R. P. J., Löwik, M. R. H., van der Berg, H., de Groot, L. C., Haller, J., Moreiras, O . and van Staveren, W. A. Serum vitamin D concentrations among elderly people in Europe. Lancet, 346. 207-210, 1995.